- Drugs
- Monday, 16 Oct 2023
US Mail Order Pharmacy Market is expected to reach US$ 1,71,883.03 million by 2030
According to our new research study on “US Mail Order Pharmacy Market Size and Forecast to 2030 – Country Analysis – by Drug Type, Product, and Mode of Order,” the market is expected to grow from US$ 43,728.62 million in 2022 to US$ 1,71,883.03 million by 2030; it is estimated to record a CAGR of 18.66% during 2022-2030. Factors such as the increasing incidences of chronic diseases and increasing adoption of mail order pharmacy services for specific healthcare needs. However, security concerns originating from counterfeit products and lack of pharmacists counselling hinders the market growth.
A Mail Order Pharmacy operates over the internet and is used for dispensing outpatient prescriptions through e-mails, shipping companies, or online pharmacies. Mail order pharmacies are a legal and advantageous way to get prescription or non-prescription drugs delivered to doorstep at a lower cost than local pharmacies. Many mail-order pharmacies provide 30 to 90 days of medication supply in two days or two weeks of time.
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00030083
The US Mail Order Pharmacy market is segmented on the basis of drug type, product, and mode of order. Based on drug type, the market is bifurcated into prescription and non-prescription drugs. The prescription medicine segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during the forecast period. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, and the rising cases of orphan diseases are likely to benefit the US mail order pharmacy market for the prescription drugs segment. By product the US Mail Order Pharmacy market is segmented into dermal care products, antidiabetic medicines, cardiovascular medicines, blood pressure medicines, asthma management products, cold & flu medicines, painkillers, antacids, and others. The dermal care product segment held a larger market share in 2022 and the cardiovascular medicines segment is anticipated to register a higher CAGR of 22.89% during the forecast period. In terms of mode of order, the market is segmented as online stores and pharmacy applications.
The number of mail-order pharmacy start-ups is increasing in the US owing to a growing inflow of investments, dependency on the internet, and demand for hassle-free medication deliveries.
Recent investments in mail-order pharmacy start-ups are mentioned below:
- In January 2020, Alto (San Francisco) raised US$ 250 million from SoftBank’s Vision Fund 2. The company delivers prescription drugs in California, Nevada, Washington, and Colorado.
- In July 2020, Medly Pharmacy (New York City) scored US$ 100 million in the series B funding round. The company provides same-day prescription delivery and works directly with patients to manage adherence to medication and refills. It is currently operating through 5 pharmacies across New York, New Jersey, Pennsylvania, Maryland, and Miami. With the investment mentioned above, it is planning to expand to other metropolitan cities in the next 18 months.
- In July 2020, Truepill raised US$ 25 million to fulfill its plans to expand into the telehealth segment with a service that will connect physicians and patients in the US over real-time video communications. With this new investment, Truepill targets to serve the increasing demand of its wide base of customers across the healthcare sector.
Therefore, these investments in mail-order pharmacy start-ups have led to a rise in the number of independent mail-order pharmacies, thus offering numerous opportunities for the expansion of this business in US during 2022-2030.
US Mail Order Pharmacy Market: Competitive Landscape and Key Developments
The major players in the US mail order pharmacy market are CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Geisinger Health, Humana, Inc., Ridgeway Pharmacy LLC and The Cigna Group. These leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Alligator Bioscience Presents Promising Interim Phase I Data for its Bispecific Drug Candidate ATOR-1015 at AACR
Apr 27, 2020
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Dec 27, 2019
Infectious Disease Therapeutics Market is expected to reach US$ 1,67,883.93 million by 2030
Jan 25, 2024
MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry
Jun 27, 2020
Asia Pacific Transdermal Drug Delivery System Market Prospects & Upcoming Trends and Opportunities Upto 2027
Sep 05, 2020
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
Dec 24, 2019
Purina Pro Plan Announces the First and Only Allergen-Reducing Cat Food
Feb 26, 2020